Literature DB >> 20634434

Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease.

J Anthony Brandon1, Jacqueline Perez, C Darrell Jennings, Donald A Cohen, V J Sindhava, S Bondada, Alan M Kaplan, J Scott Bryson.   

Abstract

The murine model of cyclosporine A (CsA)-induced syngeneic graft-versus-host disease (SGVHD) is a bone marrow (BM) transplantation model that develops chronic colon inflammation identical to other murine models of CD4(+) T cell-mediated colitis. Interestingly, SGVHD animals develop chronic liver lesions that are similar to the early peribiliary inflammatory stages of clinical chronic liver disease, which is frequently associated with inflammatory bowel disease (IBD). Therefore, studies were initiated to investigate the chronic liver inflammation that develops in the SGVHD model. To induce SGVHD, mice were lethally irradiated, reconstituted with syngeneic BM, and treated with CsA. All of the SGVHD animals that developed colitis also develop chronic liver inflammation. Liver samples from control and SGVHD animals were monitored for tissue pathology, RNA for inflammatory mediators, and phenotypic analysis and in vitro reactivity of the inflammatory infiltrate. Diseased animals developed lesions of intrahepatic and extrahepatic bile ducts. Elevated levels of mRNA for molecules associated with chronic liver inflammation, including mucosal cellular adhesion molecule -1, the chemokines CCL25, CCL28, CCR9, and T(H)1- and T(H)17-associated cytokines were observed in livers of SGVHD mice. CD4(+) T cells were localized to the peribiliary region of the livers of diseased animals, and an enhanced proliferative response of liver-associated mononuclear cells against colonic bacterial antigens was observed. The murine model of SGVHD colitis may be a valuable tool to study the entero-hepatic linkage between chronic colon inflammation and inflammatory liver disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634434      PMCID: PMC2950686          DOI: 10.1152/ajpgi.00511.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  64 in total

1.  An interleukin-6-neutralizing antibody prevents cyclosporine-induced nephrotoxicity in mice.

Authors:  Mark LaSpina; Sudipta Tripathi; Louis A Gatto; David Bruch; Kristopher G Maier; Dilip S Kittur
Journal:  J Surg Res       Date:  2008-01-29       Impact factor: 2.192

2.  p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ.

Authors:  Birgit Terjung; Jennifer Söhne; Berthold Lechtenberg; Judith Gottwein; Marit Muennich; Volker Herzog; Michael Mähler; Tilman Sauerbruch; Ulrich Spengler
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

3.  Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis.

Authors:  K Harada; S Shimoda; Y Sato; K Isse; H Ikeda; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 4.  Hepatobiliary associations with inflammatory bowel disease.

Authors:  Crystal Knight; Karen F Murray
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-12       Impact factor: 3.869

Review 5.  Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?

Authors:  Birgit Terjung; Ulrich Spengler
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

6.  Adoptive transfer of murine syngeneic graft-vs.-host disease by CD4+ T cells.

Authors:  J Scott Bryson; C Darrell Jennings; Jason A Brandon; Jacqueline Perez; Betty E Caywood; Alan M Kaplan
Journal:  J Leukoc Biol       Date:  2007-08-28       Impact factor: 4.962

7.  Hepatic IL-17 responses in human and murine primary biliary cirrhosis.

Authors:  Ruth Y Z Lan; Thucydides L Salunga; Koichi Tsuneyama; Zhe-Xiong Lian; Guo-Xiang Yang; Willy Hsu; Yuki Moritoki; Aftab A Ansari; Claudia Kemper; Jeff Price; John P Atkinson; Ross L Coppel; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-12-19       Impact factor: 7.094

8.  Hepatitis resulting from liver-specific expression and recognition of self-antigen.

Authors:  James Buxbaum; Peiqing Qian; Paul M Allen; Marion G Peters
Journal:  J Autoimmun       Date:  2008-06-02       Impact factor: 7.094

9.  Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.

Authors:  Fouad Lafdil; Hua Wang; Ogyi Park; Weici Zhang; Yuki Moritoki; Shi Yin; Xin Yuan Fu; M Eric Gershwin; Zhe-Xiong Lian; Bin Gao
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

10.  Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population.

Authors:  G Rong; Y Zhou; Y Xiong; L Zhou; H Geng; T Jiang; Y Zhu; H Lu; S Zhang; P Wang; B Zhang; R Zhong
Journal:  Clin Exp Immunol       Date:  2009-03-02       Impact factor: 4.330

View more
  1 in total

1.  A gut feeling about murine syngeneic GVHD.

Authors:  J Scott Bryson; J Anthony Brandon; C Darrell Jennings; Alan M Kaplan
Journal:  Chimerism       Date:  2011-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.